Arrowhead Research | ARWR - Ativos

Preço das Ações
73.91
Mudança Diária
-0.49 -0.66%
Mensal
21.62%
Anual
457.81%
Q2 Previsão
72.33




Ativos Alterar Data
Agios Pharmaceuticals USD 1.3B 88.48M 2025-12
Alnylam Pharmaceuticals USD 4.97B 114.67M 2025-12
Anika Therapeutics USD 190.27M 833K 2025-12
Arrowhead Research USD 1.6B 218.89M 2025-12
Heron Therapeutics USD 255.88M 6.93M 2025-12
Incyte USD 6.96B 627.62M 2025-12
Ionis Pharmaceuticals USD 3.52B 490.91M 2025-12
Ligand Pharmaceuticals USD 1.56B 83.86M 2025-12
Merck USD 129.55B 12.02B 2025-09
Moderna USD 12.34B 203M 2025-12
Nektar Therapeutics USD 280.41M 20.94M 2025-12
Novartis USD 110.95B 3.66B 2025-12
Sarepta Therapeutics USD 3.35B 143.73M 2025-12
TG Therapeutics USD 1.06B 38.23M 2025-12
Ultragenyx Pharmaceutical USD 1.53B 341.56M 2025-12
Vertex Pharmaceuticals USD 25.64B 780.7M 2025-12
Xencor USD 875.5M 6.68M 2025-12